跳至主要内容
临床试验/CTRI/2020/03/024213
CTRI/2020/03/024213Other不适用

Drug Utilisation Evaluation of antibiotics and the prevalence of multidrug resistant Urinary Tract Infection in a tertiary care hospital in South India.

Asthaa Malhotra1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年3月25日最近更新:

试验速览

阶段
不适用
状态
Other
发起方
入组人数
100
试验地点
1
主要终点
Drug Utilisation Evaluation of multi drug resistant Urinary Tract Infection.

研究概览

简要总结

Urinary tract infections are the second most common infections that drive the use of antibiotics, an estimate of 150 million UTIs occur every year globally, this has led to increasing use of empirical therapy and bacterial resistance which in turn cascades into increased treatment failures. Various studies show clear increase in antibiotic resistance among uropathogens. Recurrent urinary tract infections (UTI) are common among young healthy women even though they generally have anatomically and physiologically normal urinary tracts. Hence, the surveillance of antibiotic susceptibility pattern is essential for the appropriate treatment and reduced remission of infection. There is a lack of literature on the prevalence of MDR UTI in South India therefore, this study is carried out to depict the treatment pattern and prevalence of MDR UTI in a 2000 bedded hospital in Karnataka to improve the quality of treatment of patients.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients with final diagnosis of UTI resistant to three or more than three classes of antibiotics.

排除标准

  • Patients file with incomplete data.

结局指标

主要结局

Drug Utilisation Evaluation of multi drug resistant Urinary Tract Infection.

时间窗: 10 days

次要结局

  • Most common resistant bacteria(Most common resistant drug)

研究者

发起方
Asthaa Malhotra
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验